AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Amarillo Biosciences Gets Grant To Develop H. pylori Vaccine.(Brief Article)
2001 DEC 5 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc., (AMAR) has received a small business innovative research (SBIR) grant of $96,248 from the U.S. National Institutes of Health (NIH) to develop a vaccine to combat Helicobacter pylori, a major cause of gastric cancer. Amarillo Biosciences will collaborate with Steven Krakowka, DVM, PhD, of the Ohio State University and John Ellis, DVM, PhD, of Capricorn Research and Development, Laramie, Wyoming.
H. pylori is a spiral-shaped bacterium found in the stomach of humans that causes more than 90% of duodenal ulcers and up to 80% of gastric ulcers. Approximately two-thirds of the world's human population is infected with H. pylori. In developing countries, infection is frequently symptomatic and is responsible for the high incidence of gastric cancer. The cost and expense of pharmacological intervention is beyond the means of most of the population. A safe and efficacious vaccine would provide an economical and a widespread benefit to the ...
- Amarillo Biosciences, Inc. Receives SBIR Grant to Develop Vaccine For...
- Press release article from: PR Newswire October 16, 2001 700+ words
...be used by Amarillo Biosciences to develop...gastric cancer. Amarillo Biosciences will collaborate...PhD of The Ohio State University...and CEO of Amarillo Biosciences, Inc. said...partner with The Ohio State University...
- Amarillo Biosciences Names Members of Committee to Develop an Alternative To...
- Press release article from: PR Newswire September 30, 2003 700+ words
Amarillo Biosciences, Inc. (BULLETIN...President and CEO Amarillo Biosciences, Inc. Amarillo...Krakowka, DVM, PhD The Ohio State University Department...jointly proposed by Amarillo Biosciences, Inc., and one...
- Amarillo Biosciences Licenses Low-Dose Oral Interferon Rights to NOBEL to Treat...
- Press release article from: PR Newswire September 14, 2004 700+ words
...Total Population of 365 Million Amarillo Biosciences, Inc. (BULLETIN BOARD: AMAR...indication of Behcet's Disease to Amarillo Biosciences. The Orphan Drug Designation is...Cummins, President and CEO of Amarillo Biosciences. "In Turkey alone, the market...
- Amarillo Biosciences Joins Asia's War on SARS.
- Press release article from: PR Newswire June 2, 2003 700+ words
Amarillo Biosciences, Inc. (BULLETIN BOARD: AMAR...Fortunately, past research studies by Amarillo Biosciences have determined that low-dose...toxic way, as demonstrated by Amarillo Biosciences' published (Vet Immunology...
- Amarillo Biosciences Requests Designated New Animal Drug Listing for Ten...
- Press release article from: PR Newswire September 9, 2004 700+ words
...Conduct Studies on Approved Listings Amarillo Biosciences, Inc. (BULLETIN BOARD: AMAR...grants that it will be seeking, Amarillo Biosciences intends to fund a number of studies...successful outcome of these studies, Amarillo Biosciences would be able to commence marketing...
- Amarillo Biosciences Reports New Patent Issues in USA and Japan
- Press release article from: PR Newswire July 13, 1998 700+ words
...Texas, July 13 /PRNewswire/ -- Amarillo Biosciences Inc. (Nasdaq: AMAR) today announced...The U.S. patent will grant Amarillo Biosciences' claims to the use of low dose...Cummins, president and CEO of Amarillo Biosciences. Amarillo Biosciences maintains...
- Amarillo Biosciences Supports a Campaign to Protect Livestock Against Agro-...
- Press release article from: PR Newswire August 22, 2003 700+ words
...President and founding CEO of Amarillo Biosciences, Inc. (BULLETIN BOARD: AMAR...depopulation jointly proposed by Amarillo Biosciences, Inc. and an agricultural company...protection at a much lower cost. Amarillo Biosciences, Inc., a pharmaceutical research...
- Amarillo Biosciences Announces New License Agreements
- Press release article from: PR Newswire September 30, 1997 700+ words
...30 /PRNewswire/ -- Amarillo Biosciences Inc. (Nasdaq: AMAR...working relationship with Amarillo Biosciences. Currently it and its...approximately 28 percent of Amarillo Biosciences' shares and have board...